National Vaccine Injury Compensation Program; List of Petitions Received, 11373-11375 [2020-03980]

Download as PDF Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices eSTAR Pilot Program through the procedures outlined on the voluntary eSTAR Pilot Program website. Non-pilot participants are welcome to submit feedback to the Docket (see ADDRESSES). During the voluntary eSTAR Pilot Program, CDRH staff intends to be available to answer questions or concerns that may arise. C. Targeted Questions FDA requests responses to the following questions about eSTAR from pilot program participants and stakeholders outside the pilot who want to submit comments to the docket. (1) Is eSTAR able to integrate into your organization’s business process? (2) Are you able to open eSTAR, and are you able to add values to the structured data fields, as well as add attachments? Once entered and added, are the data retained after closing and reopening eSTAR? (3) If you use Assistive Technology, are you able to navigate through and complete eSTAR? (4) If eSTAR is not intuitive to use, why? (5) Is the organization and content in eSTAR as expected, or do you have suggestions for improvement? (6) Is eSTAR able to accommodate PDF attachments that are of the size you typically would provide in a submission? (7) If all the required questions (indicated by red or green indicators) are provided values, and all the required attachments are added, does eSTAR properly indicate it is complete on the first page, and are all the sections listed in the ‘‘Completed’’ column in the final section? (8) Do you have any suggestions to improve the effectiveness of eSTAR in its purpose, or suggestions to improve the usability? II. Paperwork Reduction Act of 1995 This notice refers to previously approved FDA collections of information. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3521). The collections of information in 21 CFR part 807, subpart E have been approved under OMB control number 0910–0120. lotter on DSKBCFDHB2PROD with NOTICES III. References The following references are on display in the Dockets Management Staff (see ADDRESSES), and are available for viewing by interested persons between 9 a.m. and 4 p.m., Monday through Friday; they are also available electronically at https:// VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 www.regulations.gov. FDA has verified the website addresses, as of the date this document publishes in the Federal Register, but websites are subject to change over time. 1. MDUFA III Commitment Letter, available at: https://www.fda.gov/downloads/ MedicalDevices/NewsEvents/ WorkshopsConferences/UCM295454.pdf. 2. FDA Guidance for Industry and FDA Staff ‘‘eCopy Program for Medical Device Submissions,’’ dated October 10, 2013. This document was superseded by the guidance of the same title dated December 16, 2019, available at: https:// www.fda.gov/regulatory-information/ search-fda-guidance-documents/ecopyprogram-medical-device-submissions. 3. MDUFA IV Commitment Letter, available at: https://www.fda.gov/media/102699/ download. 4. Quality in 510(k) Review Program Pilot, available at: https://www.fda.gov/ medical-devices/premarket-notification510k/510k-program-pilots#quik. 5. FDA Guidance for Industry and FDA Staff ‘‘Refuse to Accept Policy for 510(k)s,’’ dated September 13, 2019, available at: https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments/refuse-accept-policy-510ks. 6. FDA Guidance for Industry and FDA Staff ‘‘The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)],’’ dated July 28, 2014, available at: https://www.fda.gov/ regulatory-information/search-fdaguidance-documents/510k-programevaluating-substantial-equivalencepremarket-notifications-510k. Dated: February 21, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–03945 Filed 2–26–20; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Vaccine Injury Compensation Program; List of Petitions Received Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by Section 2112(b)(2) of the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is SUMMARY: PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 11373 charged by statute with responsibility for considering and acting upon the petitions. FOR FURTHER INFORMATION CONTACT: For information about requirements for filing petitions, and the Program in general, contact Lisa L. Reyes, Clerk of Court, United States Court of Federal Claims, 717 Madison Place NW, Washington, DC 20005, (202) 357–6400. For information on HRSA’s role in the Program, contact the Director, National Vaccine Injury Compensation Program, 5600 Fishers Lane, Room 08N146B, Rockville, Maryland 20857; (301) 443– 6593, or visit our website at: https:// www.hrsa.gov/vaccinecompensation/ index.html. SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault compensation for certain individuals who have been injured by specified childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 300aa– 10 et seq., provides that those seeking compensation are to file a petition with the United States Court of Federal Claims and to serve a copy of the petition to the Secretary of HHS, who is named as the respondent in each proceeding. The Secretary has delegated this responsibility under the Program to HRSA. The Court is directed by statute to appoint special masters who take evidence, conduct hearings as appropriate, and make initial decisions as to eligibility for, and amount of, compensation. A petition may be filed with respect to injuries, disabilities, illnesses, conditions, and deaths resulting from vaccines described in the Vaccine Injury Table (the Table) set forth at 42 CFR 100.3. This Table lists for each covered childhood vaccine the conditions that may lead to compensation and, for each condition, the time period for occurrence of the first symptom or manifestation of onset or of significant aggravation after vaccine administration. Compensation may also be awarded for conditions not listed in the Table and for conditions that are manifested outside the time periods specified in the Table, but only if the petitioner shows that the condition was caused by one of the listed vaccines. Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa–12(b)(2), requires that ‘‘[w]ithin 30 days after the Secretary receives service of any petition filed under section 2111 the Secretary shall publish notice of such petition in the Federal Register.’’ Set forth below is a list of petitions received by HRSA on January 1, 2020, through January 31, 2020. This list provides the name of petitioner, city and state of vaccination E:\FR\FM\27FEN1.SGM 27FEN1 11374 Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices lotter on DSKBCFDHB2PROD with NOTICES (if unknown then city and state of person or attorney filing claim), and case number. In cases where the Court has redacted the name of a petitioner and/or the case number, the list reflects such redaction. Section 2112(b)(2) also provides that the special master ‘‘shall afford all interested persons an opportunity to submit relevant, written information’’ relating to the following: 1. The existence of evidence ‘‘that there is not a preponderance of the evidence that the illness, disability, injury, condition, or death described in the petition is due to factors unrelated to the administration of the vaccine described in the petition,’’ and 2. Any allegation in a petition that the petitioner either: a. ‘‘[S]ustained, or had significantly aggravated, any illness, disability, injury, or condition not set forth in the Vaccine Injury Table but which was caused by’’ one of the vaccines referred to in the Table, or b. ‘‘[S]ustained, or had significantly aggravated, any illness, disability, injury, or condition set forth in the Vaccine Injury Table the first symptom or manifestation of the onset or significant aggravation of which did not occur within the time period set forth in the Table but which was caused by a vaccine’’ referred to in the Table. In accordance with Section 2112(b)(2), all interested persons may submit written information relevant to the issues described above in the case of the petitions listed below. Any person choosing to do so should file an original and three (3) copies of the information with the Clerk of the United States Court of Federal Claims at the address listed above (under the heading FOR FURTHER INFORMATION CONTACT), with a copy to HRSA addressed to Director, Division of Injury Compensation Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B, Rockville, Maryland 20857. The Court’s caption (Petitioner’s Name v. Secretary of HHS) and the docket number assigned to the petition should be used as the caption for the written submission. Chapter 35 of title 44, United States Code, related to paperwork reduction, does not apply to information required for purposes of carrying out the Program. Dated: February 20, 2020. Thomas J. Engels, Administrator. List of Petitions Filed 1. Corey Silvers, Medora, Indiana, Court of Federal Claims No: 20–0001V 2. Kristi Austin, Grand Forks, North Dakota, Court of Federal Claims No: 20–0002V 3. Ruth B. Thompson on behalf of The Estate VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 of Richard D. Thompson, Deceased, Washington, District of Columbia, Court of Federal Claims No: 20–0003V 4. Amy Turner, Englewood, New Jersey, Court of Federal Claims No: 20–0004V 5. Beverly Hathcock, Phoenix, Arizona, Court of Federal Claims No: 20–0005V 6. Elaine Vasilopoulos, Glen Oaks, New York, Court of Federal Claims No: 20–0006V 7. Nancy Clark, Washington, District of Columbia, Court of Federal Claims No: 20–0007V 8. Patricia C. Puccio, Prairieville, Louisiana, Court of Federal Claims No: 20–0008V 9. Jason Berberich, Fargo, North Dakota, Court of Federal Claims No: 20–0010V 10. Amanda Jacobs, Charleston, South Carolina, Court of Federal Claims No: 20–0011V 11. Ana Cruz De Jesus, Denver, Colorado, Court of Federal Claims No: 20–0013V 12. Frank Rosseter, Torrington, Connecticut, Court of Federal Claims No: 20–0014V 13. Nico Ghasemipor, Deceased, Waltham, Massachusetts, Court of Federal Claims No: 20–0017V 14. Loren Lynette Machuca on behalf of J.A.M., San Benito, Texas, Court of Federal Claims No: 20–0018V 15. Pamela Stewart, Louisville, Kentucky, Court of Federal Claims No: 20–0019V 16. Kevin Harris, Ada, Oklahoma, Court of Federal Claims No: 20–0020V 17. Keith Irish, Manchester, New Hampshire, Court of Federal Claims No: 20–0021V 18. Erica Stastny, Louisville, Kentucky, Court of Federal Claims No: 20–0022V 19. Megan Zynkian, San Diego, California, Court of Federal Claims No: 20–0023V 20. Paoshoua Vue, Stockton, California, Court of Federal Claims No: 20–0024V 21. Lexi Kestner, Chicago, Illinois, Court of Federal Claims No: 20–0025V 22. Jamar Simmons, Bagram Air Field, Afghanistan, Court of Federal Claims No: 20–0026V 23. Ron Richards and Samantha Richards on behalf of Caleb Lee/Carter Albert HallRichards, Ashtabula, Ohio, Court of Federal Claims No: 20–0028V 24. Sheri Boatwright, Sacramento, California, Court of Federal Claims No: 20–0029V 25. Paula Beyerl, Leesburg, Virginia, Court of Federal Claims No: 20–0032V 26. Loretta Franklin, Webster, New York, Court of Federal Claims No: 20–0033V 27. Stacey Cyrus, Boston, Massachusetts, Court of Federal Claims No: 20–0035V 28. Shavon Dickinson on behalf of Z.D., Sacramento, California, Court of Federal Claims No: 20–0038V 29. Terrance Finefrock, Tucson, Arizona, Court of Federal Claims No: 20–0042V 30. Margo Paluilis, Brattleboro, Vermont, Court of Federal Claims No: 20–0043V 31. Dania Pedraza on behalf of N.Q., Brownsville, Texas, Court of Federal Claims No: 20–0045V 32. Sherry Davis, Longview, Washington, Court of Federal Claims No: 20–0046V 33. John Hutton, Folsom, California, Court of Federal Claims No: 20–0049V 34. Deandrea Austin on behalf of D.F., Detroit, Michigan, Court of Federal Claims No: 20–0050V 35. Janet Jackson, Cerro Gordo, Illinois, Court PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 of Federal Claims No: 20–0051V 36. Angelia Johnson, Winston Salem, North Carolina, Court of Federal Claims No: 20–0054V 37. Rhonda Rose, Berea, Kentucky, Court of Federal Claims No: 20–0056V 38. Josephine Inyang, Golden Valley, Minnesota, Court of Federal Claims No: 20–0057V 39. Racquel Deville, Boston, Massachusetts, Court of Federal Claims No: 20–0058V 40. Marlene Borman, Valley Stream, New York, Court of Federal Claims No: 20– 0059V 41. Erin Harland, Franklin, Tennessee, Court of Federal Claims No: 20–0060V 42. Bruce A. Ling, Jr., Quincy, Florida, Court of Federal Claims No: 20–0061V 43. Laura Hamilton on behalf of D.H., Boston, Massachusetts, Court of Federal Claims No: 20–0062V 44. Karen J. Darling, Breese, Illinois, Court of Federal Claims No: 20–0063V 45. Caprice Angelica Marcum, Modesto, California, Court of Federal Claims No: 20–0065V 46. Karla Knox, Lewistown, Montana, Court of Federal Claims No: 20–0067V 47. Michelle Mott, Dallas, Texas, Court of Federal Claims No: 20–0068V 48. Mallyssa Day, Biddeford, Maine, Court of Federal Claims No: 20–0070V 49. Debra S. DeYoung, Richmond, Virginia, Court of Federal Claims No: 20–0072V 50. Richard Joseph Spahr, Mt. Pleasant, South Carolina, Court of Federal Claims No: 20–0074V 51. Mark Chase on behalf of Barbara PauleyChase, Deceased, Goodyear, Arizona, Court of Federal Claims No: 20–0076V 52. Henry Scott McClain, Boston, Massachusetts, Court of Federal Claims No: 20–0078V 53. Laurie A. Sutherland, Fayetteville, New York, Court of Federal Claims No: 20– 0082V 54. Natalie Gorham, Memphis, Tennessee, Court of Federal Claims No: 20–0083V 55. Kenneth Leroy Collins, Jr., Fayetteville, North Carolina, Court of Federal Claims No: 20–0084V 56. Tamatha Kelly, Lakeland, Florida, Court of Federal Claims No: 20–0085V 57. Dwight Johnson, Lebanon, Pennsylvania, Court of Federal Claims No: 20–0088V 58. Jaclyn Russo on behalf of Carly Mann, Martinez, California, Court of Federal Claims No: 20–0089V 59. Jody Bidlack, Boston, Massachusetts, Court of Federal Claims No: 20–0093V 60. Jane Doe, Washington, District of Columbia, Court of Federal Claims No: 20–0094V 61. Joanna Villalobos on behalf of A.D., Harlingen, Texas, Court of Federal Claims No: 20–0096V 62. Patricia Snelson, Saint Charles, Missouri, Court of Federal Claims No: 20–0098V 63. Sharon Issertell, Roseville, California, Court of Federal Claims No: 20–0099V 64. Mazin Khayat, Plantation, Florida, Court of Federal Claims No: 20–0101V 65. Kenya Dixon, Jackson, Mississippi, Court of Federal Claims No: 20–0102V 66. Schantel Purvis, Orange Park, Florida, Court of Federal Claims No: 20–0103V E:\FR\FM\27FEN1.SGM 27FEN1 Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices 67. Brenda J. Underwood, Richmond, Virginia, Court of Federal Claims No: 20– 0104V 68. Dennis Vivians, Bethesda, Maryland, Court of Federal Claims No: 20–0105V 69. Wesley Faske, Houston, Texas, Court of Federal Claims No: 20–0106V 70. Elissa DiPasquale, Commack, New York, Court of Federal Claims No: 20–0108V 71. Eva Gordon, Dallas, Texas, Court of Federal Claims No: 20–0109V 72. Tina Schaum-Hoey, Baltimore, Maryland, Court of Federal Claims No: 20–0110V 73. Camila Wagner, Lone Tree, Colorado, Court of Federal Claims No: 20–0111V 74. Angela Bulan Bogue, Youngsville, North Carolina, Court of Federal Claims No: 20–0112V 75. Angela Bulan Bogue, Youngsville, North Carolina, Court of Federal Claims No: 20–0113V 76. Teresa Washington-Jenkins, Lancaster, Pennsylvania, Court of Federal Claims No: 20–0114V [FR Doc. 2020–03980 Filed 2–26–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSKBCFDHB2PROD with NOTICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. NAME: National Committee on Vital and Health Statistics (NCVHS), Full Committee Meeting. DATES AND TIMES: Tuesday, March 24, 2020: 9:00 a.m.– 5:30 p.m. Wednesday, March 25, 2020: 8:30 a.m.– 3:00 p.m. PLACE: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW, Rm. 505A, Washington, DC 20201. STATUS: Open. PURPOSE: At the March 24–25, 2020 meeting, the Committee will welcome four new NCVHS members, review and discuss a recent request received from the Designated Standard Maintenance Organizations (DSMO), receive briefings from HHS officials to inform discussion of the Committee’s workplan, and hold discussions on several health data policy topics. The Subcommittee on Standards will lead the Committee in a discussion of the most recent change request received from the DSMO taking into consideration input from stakeholders regarding costs and benefits of implementing the most recent version of the National Council for Prescription VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 11375 drug Programs (NCPDP) pharmacy standard (NCPDP F6). The Health Insurance Portability and Accountability Act (HIPAA) of 1996, as amended,1 gives statutory authority to the Secretary of Health & Human Services (HHS) to promulgate regulations adopting standards, code sets, and identifiers to support the exchange of electronic health information between covered entities. The standards are for retail pharmacy and medical transactions. New versions of the adopted standards may be brought forward to NCVHS by the standards development organizations (SDOs) or through the DSMO after completion of a consensus-based review and evaluation process. The Committee’s intent is to understand the changes in version F6 and whether there are substantive changes which need to be evaluated that would significantly change the Committee’s recommendation to HHS submitted in 2018. There is no change to the Batch Standard Implementation Guide Version 15 and the Subrogation Implementation Guide for Batch Standard Version 10, which were included in the May 2018 NCVHS recommendation. The Committee requests input and comments from the public in advance of this meeting to inform its deliberations about the benefits or costs of changing to this new version. The change request letter and change log are available for review at https://ncvhs.hhs.gov/Letter-to-NCVHSDSMO-Change-Request-January-212020. Please submit comments specific to the impact of the change from version F2 to F6 to NCVHSmail@cdc.gov by close of business Friday, March 13, 2020. The Subcommittee on Standards will introduce a new project scoping statement for its work on convergence of administrative and clinical data standards using the prior authorization transaction as a use-case. The Subcommittee will also provide an update on its activities in collaboration with the Office of the National Coordinator for Health Information Technology (ONC) and the Health Information Technology Advisory Committee (HITAC) regarding the opportunity for burden reduction through convergence of administrative and clinical data standards using the prior authorization transaction as a usecase. The Subcommittee on Privacy, Confidentiality and Security will lead a discussion of the full Committee to assess priority areas for focus and activity. HHS agencies will brief the Committee regarding recent and ongoing work to inform the Committee’s discussion of the 2020 workplan. There will be a public comment period on both meeting days. The times and topics are subject to change. Please refer to the posted agenda for any updates. CONTACT PERSON FOR MORE INFORMATION: Substantive program information may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone (301) 458–4715. Summaries of meetings and a roster of Committee members are available on the home page of the NCVHS website: www.ncvhs.hhs.gov, where further information including an agenda and instructions to access the broadcast of the meeting will also be posted. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (770) 488–3210 as soon as possible. 1 Along with Section 1104 (c) of the Affordable Care Act. Name of Committee: National Institute of Allergy and Infectious Diseases Special PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Dated: February 20, 2020. Sharon Arnold, Associate Deputy Assistant Secretary for Planning and Evaluation, Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2020–03981 Filed 2–26–20; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 85, Number 39 (Thursday, February 27, 2020)]
[Notices]
[Pages 11373-11375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03980]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


National Vaccine Injury Compensation Program; List of Petitions 
Received

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HRSA is publishing this notice of petitions received under the 
National Vaccine Injury Compensation Program (the Program), as required 
by Section 2112(b)(2) of the Public Health Service (PHS) Act, as 
amended. While the Secretary of HHS is named as the respondent in all 
proceedings brought by the filing of petitions for compensation under 
the Program, the United States Court of Federal Claims is charged by 
statute with responsibility for considering and acting upon the 
petitions.

FOR FURTHER INFORMATION CONTACT: For information about requirements for 
filing petitions, and the Program in general, contact Lisa L. Reyes, 
Clerk of Court, United States Court of Federal Claims, 717 Madison 
Place NW, Washington, DC 20005, (202) 357-6400. For information on 
HRSA's role in the Program, contact the Director, National Vaccine 
Injury Compensation Program, 5600 Fishers Lane, Room 08N146B, 
Rockville, Maryland 20857; (301) 443-6593, or visit our website at: 
https://www.hrsa.gov/vaccinecompensation/.

SUPPLEMENTARY INFORMATION: The Program provides a system of no-fault 
compensation for certain individuals who have been injured by specified 
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 
300aa-10 et seq., provides that those seeking compensation are to file 
a petition with the United States Court of Federal Claims and to serve 
a copy of the petition to the Secretary of HHS, who is named as the 
respondent in each proceeding. The Secretary has delegated this 
responsibility under the Program to HRSA. The Court is directed by 
statute to appoint special masters who take evidence, conduct hearings 
as appropriate, and make initial decisions as to eligibility for, and 
amount of, compensation.
    A petition may be filed with respect to injuries, disabilities, 
illnesses, conditions, and deaths resulting from vaccines described in 
the Vaccine Injury Table (the Table) set forth at 42 CFR 100.3. This 
Table lists for each covered childhood vaccine the conditions that may 
lead to compensation and, for each condition, the time period for 
occurrence of the first symptom or manifestation of onset or of 
significant aggravation after vaccine administration. Compensation may 
also be awarded for conditions not listed in the Table and for 
conditions that are manifested outside the time periods specified in 
the Table, but only if the petitioner shows that the condition was 
caused by one of the listed vaccines.
    Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2), 
requires that ``[w]ithin 30 days after the Secretary receives service 
of any petition filed under section 2111 the Secretary shall publish 
notice of such petition in the Federal Register.'' Set forth below is a 
list of petitions received by HRSA on January 1, 2020, through January 
31, 2020. This list provides the name of petitioner, city and state of 
vaccination

[[Page 11374]]

(if unknown then city and state of person or attorney filing claim), 
and case number. In cases where the Court has redacted the name of a 
petitioner and/or the case number, the list reflects such redaction.
    Section 2112(b)(2) also provides that the special master ``shall 
afford all interested persons an opportunity to submit relevant, 
written information'' relating to the following:
    1. The existence of evidence ``that there is not a preponderance of 
the evidence that the illness, disability, injury, condition, or death 
described in the petition is due to factors unrelated to the 
administration of the vaccine described in the petition,'' and
    2. Any allegation in a petition that the petitioner either:
    a. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition not set forth in the Vaccine Injury 
Table but which was caused by'' one of the vaccines referred to in the 
Table, or
    b. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition set forth in the Vaccine Injury Table 
the first symptom or manifestation of the onset or significant 
aggravation of which did not occur within the time period set forth in 
the Table but which was caused by a vaccine'' referred to in the Table.
    In accordance with Section 2112(b)(2), all interested persons may 
submit written information relevant to the issues described above in 
the case of the petitions listed below. Any person choosing to do so 
should file an original and three (3) copies of the information with 
the Clerk of the United States Court of Federal Claims at the address 
listed above (under the heading FOR FURTHER INFORMATION CONTACT), with 
a copy to HRSA addressed to Director, Division of Injury Compensation 
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B, 
Rockville, Maryland 20857. The Court's caption (Petitioner's Name v. 
Secretary of HHS) and the docket number assigned to the petition should 
be used as the caption for the written submission. Chapter 35 of title 
44, United States Code, related to paperwork reduction, does not apply 
to information required for purposes of carrying out the Program.

    Dated: February 20, 2020.
Thomas J. Engels,
Administrator.

List of Petitions Filed

1. Corey Silvers, Medora, Indiana, Court of Federal Claims No: 20-
0001V
2. Kristi Austin, Grand Forks, North Dakota, Court of Federal Claims 
No: 20-0002V
3. Ruth B. Thompson on behalf of The Estate of Richard D. Thompson, 
Deceased, Washington, District of Columbia, Court of Federal Claims 
No: 20-0003V
4. Amy Turner, Englewood, New Jersey, Court of Federal Claims No: 
20-0004V
5. Beverly Hathcock, Phoenix, Arizona, Court of Federal Claims No: 
20-0005V
6. Elaine Vasilopoulos, Glen Oaks, New York, Court of Federal Claims 
No: 20-0006V
7. Nancy Clark, Washington, District of Columbia, Court of Federal 
Claims No: 20-0007V
8. Patricia C. Puccio, Prairieville, Louisiana, Court of Federal 
Claims No: 20-0008V
9. Jason Berberich, Fargo, North Dakota, Court of Federal Claims No: 
20-0010V
10. Amanda Jacobs, Charleston, South Carolina, Court of Federal 
Claims No: 20-0011V
11. Ana Cruz De Jesus, Denver, Colorado, Court of Federal Claims No: 
20-0013V
12. Frank Rosseter, Torrington, Connecticut, Court of Federal Claims 
No: 20-0014V
13. Nico Ghasemipor, Deceased, Waltham, Massachusetts, Court of 
Federal Claims No: 20-0017V
14. Loren Lynette Machuca on behalf of J.A.M., San Benito, Texas, 
Court of Federal Claims No: 20-0018V
15. Pamela Stewart, Louisville, Kentucky, Court of Federal Claims 
No: 20-0019V
16. Kevin Harris, Ada, Oklahoma, Court of Federal Claims No: 20-
0020V
17. Keith Irish, Manchester, New Hampshire, Court of Federal Claims 
No: 20-0021V
18. Erica Stastny, Louisville, Kentucky, Court of Federal Claims No: 
20-0022V
19. Megan Zynkian, San Diego, California, Court of Federal Claims 
No: 20-0023V
20. Paoshoua Vue, Stockton, California, Court of Federal Claims No: 
20-0024V
21. Lexi Kestner, Chicago, Illinois, Court of Federal Claims No: 20-
0025V
22. Jamar Simmons, Bagram Air Field, Afghanistan, Court of Federal 
Claims No: 20-0026V
23. Ron Richards and Samantha Richards on behalf of Caleb Lee/Carter 
Albert Hall-Richards, Ashtabula, Ohio, Court of Federal Claims No: 
20-0028V
24. Sheri Boatwright, Sacramento, California, Court of Federal 
Claims No: 20-0029V
25. Paula Beyerl, Leesburg, Virginia, Court of Federal Claims No: 
20-0032V
26. Loretta Franklin, Webster, New York, Court of Federal Claims No: 
20-0033V
27. Stacey Cyrus, Boston, Massachusetts, Court of Federal Claims No: 
20-0035V
28. Shavon Dickinson on behalf of Z.D., Sacramento, California, 
Court of Federal Claims No: 20-0038V
29. Terrance Finefrock, Tucson, Arizona, Court of Federal Claims No: 
20-0042V
30. Margo Paluilis, Brattleboro, Vermont, Court of Federal Claims 
No: 20-0043V
31. Dania Pedraza on behalf of N.Q., Brownsville, Texas, Court of 
Federal Claims No: 20-0045V
32. Sherry Davis, Longview, Washington, Court of Federal Claims No: 
20-0046V
33. John Hutton, Folsom, California, Court of Federal Claims No: 20-
0049V
34. Deandrea Austin on behalf of D.F., Detroit, Michigan, Court of 
Federal Claims No: 20-0050V
35. Janet Jackson, Cerro Gordo, Illinois, Court of Federal Claims 
No: 20-0051V
36. Angelia Johnson, Winston Salem, North Carolina, Court of Federal 
Claims No: 20-0054V
37. Rhonda Rose, Berea, Kentucky, Court of Federal Claims No: 20-
0056V
38. Josephine Inyang, Golden Valley, Minnesota, Court of Federal 
Claims No: 20-0057V
39. Racquel Deville, Boston, Massachusetts, Court of Federal Claims 
No: 20-0058V
40. Marlene Borman, Valley Stream, New York, Court of Federal Claims 
No: 20-0059V
41. Erin Harland, Franklin, Tennessee, Court of Federal Claims No: 
20-0060V
42. Bruce A. Ling, Jr., Quincy, Florida, Court of Federal Claims No: 
20-0061V
43. Laura Hamilton on behalf of D.H., Boston, Massachusetts, Court 
of Federal Claims No: 20-0062V
44. Karen J. Darling, Breese, Illinois, Court of Federal Claims No: 
20-0063V
45. Caprice Angelica Marcum, Modesto, California, Court of Federal 
Claims No: 20-0065V
46. Karla Knox, Lewistown, Montana, Court of Federal Claims No: 20-
0067V
47. Michelle Mott, Dallas, Texas, Court of Federal Claims No: 20-
0068V
48. Mallyssa Day, Biddeford, Maine, Court of Federal Claims No: 20-
0070V
49. Debra S. DeYoung, Richmond, Virginia, Court of Federal Claims 
No: 20-0072V
50. Richard Joseph Spahr, Mt. Pleasant, South Carolina, Court of 
Federal Claims No: 20-0074V
51. Mark Chase on behalf of Barbara Pauley-Chase, Deceased, 
Goodyear, Arizona, Court of Federal Claims No: 20-0076V
52. Henry Scott McClain, Boston, Massachusetts, Court of Federal 
Claims No: 20-0078V
53. Laurie A. Sutherland, Fayetteville, New York, Court of Federal 
Claims No: 20-0082V
54. Natalie Gorham, Memphis, Tennessee, Court of Federal Claims No: 
20-0083V
55. Kenneth Leroy Collins, Jr., Fayetteville, North Carolina, Court 
of Federal Claims No: 20-0084V
56. Tamatha Kelly, Lakeland, Florida, Court of Federal Claims No: 
20-0085V
57. Dwight Johnson, Lebanon, Pennsylvania, Court of Federal Claims 
No: 20-0088V
58. Jaclyn Russo on behalf of Carly Mann, Martinez, California, 
Court of Federal Claims No: 20-0089V
59. Jody Bidlack, Boston, Massachusetts, Court of Federal Claims No: 
20-0093V
60. Jane Doe, Washington, District of Columbia, Court of Federal 
Claims No: 20-0094V
61. Joanna Villalobos on behalf of A.D., Harlingen, Texas, Court of 
Federal Claims No: 20-0096V
62. Patricia Snelson, Saint Charles, Missouri, Court of Federal 
Claims No: 20-0098V
63. Sharon Issertell, Roseville, California, Court of Federal Claims 
No: 20-0099V
64. Mazin Khayat, Plantation, Florida, Court of Federal Claims No: 
20-0101V
65. Kenya Dixon, Jackson, Mississippi, Court of Federal Claims No: 
20-0102V
66. Schantel Purvis, Orange Park, Florida, Court of Federal Claims 
No: 20-0103V

[[Page 11375]]

67. Brenda J. Underwood, Richmond, Virginia, Court of Federal Claims 
No: 20-0104V
68. Dennis Vivians, Bethesda, Maryland, Court of Federal Claims No: 
20-0105V
69. Wesley Faske, Houston, Texas, Court of Federal Claims No: 20-
0106V
70. Elissa DiPasquale, Commack, New York, Court of Federal Claims 
No: 20-0108V
71. Eva Gordon, Dallas, Texas, Court of Federal Claims No: 20-0109V
72. Tina Schaum-Hoey, Baltimore, Maryland, Court of Federal Claims 
No: 20-0110V
73. Camila Wagner, Lone Tree, Colorado, Court of Federal Claims No: 
20-0111V
74. Angela Bulan Bogue, Youngsville, North Carolina, Court of 
Federal Claims No: 20-0112V
75. Angela Bulan Bogue, Youngsville, North Carolina, Court of 
Federal Claims No: 20-0113V
76. Teresa Washington-Jenkins, Lancaster, Pennsylvania, Court of 
Federal Claims No: 20-0114V

[FR Doc. 2020-03980 Filed 2-26-20; 8:45 am]
 BILLING CODE 4165-15-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.